MENU
LYEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lyell Immunopharma (LYEL) Ownership - Who owns Lyell Immunopharma?

Lyell Immunopharma Inc is a clinical-stage cell therapy company... Show more

Profile

Industry
N/A
Address
201 Haskins Way
Phone
+1 650 695-0677
Employees
224
Web
https://www.lyell.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
820.02M
P/E Ratio
N/A
Total Cash
319.62M
Projected Growth
N/A
Total Debt
44.29M
Revenue
41K
Risk (Beta)
2.21
Dividend Yield
N/A
Total Cash/Share
15.05
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

LYEL
Capitalization
820M
P/E Ratio
N/A
Risk (Beta)
2.21
Dividend Yield
N/A
Total Cash
320M
Total Cash/Share
15.05
Total Debt
44.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
41K
ROE
N/A
Book Value
329M
P/B Ratio
2.49
Cash Flow
N/A
Earnings
-22.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
10.30
Current Revenue Per Employee
50.00
Dividends Per Share - Security
N/A
EBITDA
-188.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-63.41
Shares Held By Institutions
166M
Shares Outstanding - Current
21.2M
Total Liabilities
78.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
201.563
View a ticker or compare two or three
LYEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Haskins Way
Phone
+1 650 695-0677
Employees
224
Web
https://www.lyell.com